User contributions
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 16:58, 22 August 2019 (diff | hist) . . (+2,666) . . m Breast cancer (current)
- 15:55, 22 August 2019 (diff | hist) . . (-1,117) . . m Breast cancer - historical (→Paclitaxel monotherapy, q3wk {{#subobject:1cb87f|Regimen=1}}) (current)
- 15:45, 22 August 2019 (diff | hist) . . (-985) . . m Breast cancer - historical (→Paclitaxel monotherapy, q3wk {{#subobject:1cb87f|Regimen=1}})
- 15:08, 22 August 2019 (diff | hist) . . (+1,212) . . Breast cancer, HER2-positive (→Lapatinib & Trastuzumab {{#subobject:9be4d2|Regimen=1}}) (current)
- 13:39, 22 August 2019 (diff | hist) . . (+2,541) . . Breast cancer (→Cyclophosphamide monotherapy {{#subobject:fb7cyd|Regimen=1}})
- 13:25, 22 August 2019 (diff | hist) . . (+1,095) . . m Breast cancer (→Vinorelbine monotherapy {{#subobject:5c104c|Regimen=1}})
- 11:19, 22 August 2019 (diff | hist) . . (+1,185) . . Breast cancer (→Paclitaxel & Bevacizumab {{#subobject:ab5252|Regimen=1}})
- 08:55, 22 August 2019 (diff | hist) . . (+2,066) . . Breast cancer, HER2-positive (→Pertuzumab & Trastuzumab {{#subobject:b1d7b1|Regimen=1}})
- 08:20, 22 August 2019 (diff | hist) . . (+1,638) . . Breast cancer, ER/PR-positive (→Anastrozole & Goserelin {{#subobject:6e3249|Regimen=1}}) (current)
- 22:18, 21 August 2019 (diff | hist) . . (+1,405) . . Breast cancer, ER/PR-positive (→Anastrozole & Fulvestrant {{#subobject:ae2512|Regimen=1}})
- 22:12, 21 August 2019 (diff | hist) . . (+1,368) . . Breast cancer, HER2-positive (→Pertuzumab & T-DM1 {{#subobject:ffffbc|Regimen=1}})
- 19:37, 21 August 2019 (diff | hist) . . (+1,811) . . Esophageal cancer (→Ramucirumab monotherapy {{#subobject:425b15|Regimen=1}}) (current)
- 19:34, 21 August 2019 (diff | hist) . . (+1,747) . . Esophageal cancer (→Irinotecan & Mitomycin {{#subobject:dfc95f|Regimen=1}})
- 15:08, 21 August 2019 (diff | hist) . . (+31) . . m Small cell lung cancer - historical (→Regimen {{#subobject:b2c397|Variant=1}}) (current)
- 15:08, 21 August 2019 (diff | hist) . . (0) . . m Small cell lung cancer - historical (→CEV (Carboplatin/Etoposide) {{#subobject:ec321a|Regimen=1}})
- 15:07, 21 August 2019 (diff | hist) . . (+83) . . m Small cell lung cancer - historical (→TEC {{#subobject:8703fa|Regimen=1}})
- 14:36, 21 August 2019 (diff | hist) . . (+5) . . m Multiple myeloma, relapsed/refractory (→Chemotherapy) (current)
- 14:36, 21 August 2019 (diff | hist) . . (+1) . . m Allogeneic HSCT (current)
- 14:33, 21 August 2019 (diff | hist) . . (+5) . . m Peripheral T-cell lymphoma (current)
- 14:33, 21 August 2019 (diff | hist) . . (+5) . . m Diffuse large B-cell lymphoma (current)
- 14:32, 21 August 2019 (diff | hist) . . (+5) . . m Esophageal cancer (→Chemotherapy)
- 14:11, 21 August 2019 (diff | hist) . . (+260) . . m Breast cancer, HER2-positive
- 11:36, 21 August 2019 (diff | hist) . . (-24) . . m Ovarian cancer (→Paclitaxel, nanoparticle albumin-bound monotherapy {{#subobject:3eae7f|Regimen=1}}) (current)
- 11:36, 21 August 2019 (diff | hist) . . (-24) . . m Melanoma (current)
- 11:34, 21 August 2019 (diff | hist) . . (-24) . . m Pancreatic cancer (current)
- 11:34, 21 August 2019 (diff | hist) . . (+14) . . m Gastric cancer (current)
- 11:31, 21 August 2019 (diff | hist) . . (-19) . . m Bladder cancer (→Paclitaxel, nanoparticle albumin-bound monotherapy {{#subobject:fec6dd|Regimen=1}}) (current)
- 11:30, 21 August 2019 (diff | hist) . . (-499) . . m Breast cancer
- 11:06, 21 August 2019 (diff | hist) . . (-12) . . m Uveal melanoma (→TACE monotherapy {{#subobject:f96a1b|Regimen=1}}) (current)
- 11:06, 21 August 2019 (diff | hist) . . (-24) . . m Hepatocellular carcinoma (current)
- 16:54, 20 August 2019 (diff | hist) . . (+637) . . m Melanoma (→Talimogene laherparepvec monotherapy {{#subobject:PYR1|Regimen=1}})
- 16:51, 20 August 2019 (diff | hist) . . (+697) . . m Hepatocellular carcinoma (→Sorafenib monotherapy {{#subobject:b38f69|Regimen=1}})
- 16:47, 20 August 2019 (diff | hist) . . (+672) . . m Hepatocellular carcinoma (→TACE monotherapy {{#subobject:f96a1b|Regimen=1}})
- 16:34, 20 August 2019 (diff | hist) . . (+1,364) . . m Follicular lymphoma (→Rituximab monotherapy, extended course {{#subobject:e26b69|Regimen=1}}) (current)
- 16:23, 20 August 2019 (diff | hist) . . (+10) . . m Colon cancer (current)
- 16:22, 20 August 2019 (diff | hist) . . (+1,123) . . m Colon cancer (→Tegafur, Uracil, Folinic acid {{#subobject:5ed2aa|Regimen=1}})
- 16:19, 20 August 2019 (diff | hist) . . (+31) . . m Colon cancer (→Placebo)
- 13:46, 20 August 2019 (diff | hist) . . (+1,506) . . m Head and neck cancer (→Radiation therapy {{#subobject:571927|Regimen=1}}) (current)
- 11:59, 20 August 2019 (diff | hist) . . (+913) . . m Non-small cell lung cancer (→Carboplatin & Gemcitabine {{#subobject:8669e|Regimen=1}}) (current)
- 11:51, 20 August 2019 (diff | hist) . . (+752) . . m Prostate cancer (→ADT & Enzalutamide {{#subobject:79lq3c|Regimen=1}}) (current)
- 11:46, 20 August 2019 (diff | hist) . . (+55) . . m Response to treatment (→Neoadjuvant response rates) (current)
- 11:46, 20 August 2019 (diff | hist) . . (-54) . . m Response to treatment (→Progression-free survival rate at 6 months (PFS6))
- 11:46, 20 August 2019 (diff | hist) . . (+52) . . m Response to treatment (→Relapse-free interval (RFI))
- 11:42, 20 August 2019 (diff | hist) . . (+1,318) . . m Bladder cancer (→Locally advanced or metastatic disease, subsequent lines)
- 22:49, 19 August 2019 (diff | hist) . . (+1,537) . . m Non-small cell lung cancer (→Carboplatin & Gemcitabine {{#subobject:7a8bcz|Regimen=1}})
- 22:46, 19 August 2019 (diff | hist) . . (+1,504) . . m Non-small cell lung cancer (→Carboplatin & Pemetrexed {{#subobject:920f46|Regimen=1}})
- 20:08, 19 August 2019 (diff | hist) . . (+1,880) . . NTRK (→Larotrectinib monotherapy {{#subobject:e0d17a|Regimen=1}}) (current)
- 20:07, 19 August 2019 (diff | hist) . . (+1,792) . . Non-small cell lung cancer, ROS1-positive (→Crizotinib monotherapy {{#subobject:be5391|Regimen=1}}) (current)
- 20:02, 19 August 2019 (diff | hist) . . (-852) . . m Entrectinib (Rozlytrek) (current)
- 11:54, 19 August 2019 (diff | hist) . . (+5) . . m Drug index (→E) (current)
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
